Coronavirus Vaccine: States should increase the precautionary dose of the Sputnik V vaccine. Know why the central administration abruptly had to give this suggestion?
Follow TheHealthSite.com for all the latest updates on COVID-19 from in and around the world.
Fortis hospitals recently said that the Sputnik V vaccine against Covid-19 would be available as part of a restricted trial roll-out soon. Read on to know more.
Russian scientists have identified a new variant of the coronavirus in Moscow as cases across the country spiked. Here's everything we know so far.
Amid a steep surge in the COVID-19 infection cases in the country, the DGCI has approved the emergency use of Sputnik-V. Here is a brief about who all can take the jab and who all should avoid taking it.
After Covishield and Covaxin, India has given a heads up to its third Covid-19 vaccine, Sputnik-V. Here's how effective the vaccine is against the novel coronavirus.
Pharma major Dr. Reddy's Laboratories Ltd has announced that the process for Emergency Use Authorization of Russia's Sputnik V has been initiated.
The calculation is based on the analysis of 78 confirmed cases of Covid-19 identified in the placebo group (62 cases) and in the vaccine group (16 cases).
The Russian COVID-19 vaccine Sputnik V may be available in India in March after it is granted approval for Emergency Use Authorisation.
Russia is already testing the first samples of Sputnik V that were produced in India, its embassy in New Delhi said on Twitter on Friday, sharing a news story in which their vaccine czar Kirill Dmitriev was quoted.
Sputnik V: Russian authorities on Monday released a statement stating that the interim analysis of the phase 3 trial of the coronavirus vaccine showed 91.4% efficacy.
People will have to observe extra precautions during the 42 days it takes for the Sputnik V coronavirus vaccine to become effective
The development comes after Russian President Vladimir Putin tasked the government and regional authorities to kick off a free voluntary Covid-19 vaccination campaign against the infection.
High-risk groups, including medical workers and teachers, will be the first to get the shots, according to Russian President Vladimir Putin.
US Pharma giants Pfizer and Moderna have already announced the price their potential Covid-19 vaccines. The price of Sputnik V is expected to be made public next week.
The COVID-19 vaccine developed by the Chinese state-owned pharmaceutical firm Sinopharm is in still Phase III trials in the UAE, Egypt, Bahrain and Jordan.
A top official of the Gamaleya National Research Center, the developer of Russia's Sputnik V vaccine, has revealed that there have been instances of infection among trial volunteers.
The second Russian Covid-19 vaccine to get regulatory approval has been developed by the country's Vector State Research Centre of Virology and Biotechnology.
A Lancet report suggests that Sputnik V can be a strong weapon against the novel coronavirus while the Russian government discloses that it is in talks with India for the local production of this COVID-19 vaccine.
China has been using an experimental coronavirus vaccine on high-risk people, including medical professionals and border inspectors, since July.
Coronavirus Vaccine: States should increase the precautionary dose of the Sputnik V vaccine. Know why the central administration abruptly had to give this suggestion?
Follow TheHealthSite.com for all the latest updates on COVID-19 from in and around the world.
Fortis hospitals recently said that the Sputnik V vaccine against Covid-19 would be available as part of a restricted trial roll-out soon. Read on to know more.
Russian scientists have identified a new variant of the coronavirus in Moscow as cases across the country spiked. Here's everything we know so far.
Amid a steep surge in the COVID-19 infection cases in the country, the DGCI has approved the emergency use of Sputnik-V. Here is a brief about who all can take the jab and who all should avoid taking it.
After Covishield and Covaxin, India has given a heads up to its third Covid-19 vaccine, Sputnik-V. Here's how effective the vaccine is against the novel coronavirus.
Pharma major Dr. Reddy's Laboratories Ltd has announced that the process for Emergency Use Authorization of Russia's Sputnik V has been initiated.
The calculation is based on the analysis of 78 confirmed cases of Covid-19 identified in the placebo group (62 cases) and in the vaccine group (16 cases).
The Russian COVID-19 vaccine Sputnik V may be available in India in March after it is granted approval for Emergency Use Authorisation.
Russia is already testing the first samples of Sputnik V that were produced in India, its embassy in New Delhi said on Twitter on Friday, sharing a news story in which their vaccine czar Kirill Dmitriev was quoted.
Sputnik V: Russian authorities on Monday released a statement stating that the interim analysis of the phase 3 trial of the coronavirus vaccine showed 91.4% efficacy.
People will have to observe extra precautions during the 42 days it takes for the Sputnik V coronavirus vaccine to become effective
The development comes after Russian President Vladimir Putin tasked the government and regional authorities to kick off a free voluntary Covid-19 vaccination campaign against the infection.
High-risk groups, including medical workers and teachers, will be the first to get the shots, according to Russian President Vladimir Putin.
US Pharma giants Pfizer and Moderna have already announced the price their potential Covid-19 vaccines. The price of Sputnik V is expected to be made public next week.
The COVID-19 vaccine developed by the Chinese state-owned pharmaceutical firm Sinopharm is in still Phase III trials in the UAE, Egypt, Bahrain and Jordan.
A top official of the Gamaleya National Research Center, the developer of Russia's Sputnik V vaccine, has revealed that there have been instances of infection among trial volunteers.
The second Russian Covid-19 vaccine to get regulatory approval has been developed by the country's Vector State Research Centre of Virology and Biotechnology.
A Lancet report suggests that Sputnik V can be a strong weapon against the novel coronavirus while the Russian government discloses that it is in talks with India for the local production of this COVID-19 vaccine.
China has been using an experimental coronavirus vaccine on high-risk people, including medical professionals and border inspectors, since July.
